Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com
A06568 | Pages: 250 | Charts: 65 | Tables: 200 |
The global yeast extract market size was valued at $440.9 million in 2023, and is projected to reach $1 billion by 2035, growing at a CAGR of 7.5% from 2024 to 2035. The cell contents of yeast, usually Saccharomyces cerevisiae, are used to make yeast extract, a natural component. Since it is high in proteins, amino acids, vitamins, and minerals, it is used in different sector such as cosmetics and food & beverages sector. Yeast extract is a popular nutrient source for microbial and cell culture growth media in the biotechnology and pharmaceutical industries. The umami taste of this substance makes it useful as a flavor enhancer in the food and beverage sectors. Furthermore, yeast extract supports skin health and nutrition in animal feed and cosmetics. Both, liquid and dry versions are available for a variety of applications.
MARKET DYNAMICS
The yeast extract market growth is driven by a variety of uses in food, beverage, pharmaceutical, and biotechnology industries, highlighting its wide range of uses as a nutrient-dense and naturally occurring taste enhancer. The growing demand for natural and clean-label ingredients in the food and beverage sector is a major factor that is fueling the need for yeast extracts, as consumers place greater emphasis on their health and well-being. As a natural substitute for chemical additives and monosodium glutamate (MSG), yeast extract appeals to consumers who are health-conscious while still satisfying clean labeling regulations. Yeast extract is widely used in the biotechnology and pharmaceutical industries as a growth medium for microbial cultures and cell lines, which is crucial for biopharmaceutical research, vaccine manufacturing, and drug development. Its importance in these sectors has been further enhanced by rise in demand for biologics and developments in fermentation technology.
On the supply side, new developments in fermentation methods and yeast extraction techniques have improved product quality and broadened the product line to meet the unique requirements of different end-use sectors. However, the market faces challenges such as the reliance on agricultural inputs, which can affect production costs, and the volatility of raw material prices. Furthermore, yeast extract market expansion is threatened by competition from synthetic substitutes and other plant-based extracts, especially in cost-sensitive industries.
North America and Europe dominate the market owing to their well-established food processing industries as well as their sophisticated pharmaceutical and biotechnology sectors. In contrast, booming food industries, rise in health consciousness, and rising biopharmaceutical investments are propelling the rapid expansion of emerging markets in Asia-Pacific and Latin America. Due to their substantial populations and growing consumer expenditure on health-related products, China, India, and Brazil stand out as important growth markets.
Sustainability trends have an impact on the market as well; eco-friendly production methods and the usage of non-GMO yeast strains are becoming more and more important to comply with environmental standards and consumer preferences. The top companies for yeast extract are concentrating on strategic alliances, mergers, and acquisitions to increase their manufacturing capabilities and fortify their worldwide presence. Innovation in products, including the creation of yeast extracts with specialized flavors or nutritional benefits, is also essential for propelling market expansion.
In addition, the yeast extract market demand is further increased by the growing use of the extract in plant-based and alternative protein diets. The use of yeast extract in plant-based formulations due to its umami flavor and protein content is growing in popularity as global diets become more vegan and vegetarian.
As a result of its numerous applications, clean-label appeal, and contribution to the progress of biopharmaceutical and biotechnology research, the yeast extract market is poised for rapid expansion. Despite difficulties such as competition and cost fluctuations, the industry continues to develop as a result of innovation, environmental programs, and rising demand in new markets.
SEGMENT OVERVIEW
The yeast extract market is segmented on the basis of type, application, form, and region. By type, the market is divided into yeastolate, yeast extracts, and active dry yeast. By application, the market is bifurcated into pharmaceuticals and biotechnology. Further, the pharmaceuticals segment is divided into vaccine production, probiotics, antibiotic production, and biopharmaceuticals. The biotechnology segment is divided into cell culture media and enzyme production. By form, the market is bifurcated into liquid and dry. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (France, Germany, Italy, Spain, UK, Russia, and the rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and the rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, UAE, Argentina, and the rest of LAMEA).
BY TYPE
[TYPEGRAPH]
By type, the active dry yeast segment dominated the global yeast extract market in 2023 and is anticipated to maintain its dominance during the forecast period. The demand for active dry yeast, is driven by its crucial role in research, fermentation processes, and the manufacturing of biopharmaceuticals. Proteins, vitamins, and minerals found in active dry yeast, which is well-known for having a rich nutritional profile, promote microbial growth and the production of bioactive chemicals. It is widely employed in the synthesis of enzymes, vaccines, antibiotics, and other physiologically active compounds. Market expansion is facilitated by the growing pharmaceutical industry and rise in need for biotechnology developments. The use of active dry yeast in this industry is also being fueled by increase in biopharmaceutical research and development activities.
BY APPLICATION
[APPLICATIONGRAPH]
By application, the pharmaceuticals segment dominated the global yeast extract market in 2023, owing to its widespread use as a natural component in medication formulations. The bioavailability of vital amino acids, vitamins, and minerals found in yeast extract is highly valued since it improves patient absorption and medication effectiveness. It is widely utilized in the manufacturing of probiotics, vaccines, and biopharmaceuticals. Yeast extract also acts as a growth medium for enzymes and antibiotics during fermentation operations. The growing need for natural and clean-label excipients in pharmaceutical products, as well as advancements in biotechnological applications that increase the usefulness of yeast extract in medication research, are further drive the market demand.
BY FORM
[FORMGRAPH]
By form, the dry segment dominated the global yeast extract market in 2023 and is anticipated to maintain its dominance during the forecast period. The dry form segment is expanding significantly as it is widely used as a nutrient-rich medium in fermentation and cell culture procedures. Dry yeast extract, which has a long shelf life and great stability, is used extensively in the manufacturing of enzymes, vaccines, and antibiotics. Market is driven by rise in demand for biopharmaceuticals as well as developments in biotechnology. The focus of major players is on novel formulas and sustainable production. Furthermore, the need for premium yeast extract in the pharmaceutical industry is being further fueled by the increased focus on biotechnological research and development on a global scale.
BY REGION
[REGIONGRAPH]
Region-wise, Europe is predicted to dominate the market with the largest yeast extract market share during the yeast extract market forecast period. The yeast extract market in Europe is expanding significantly as a result of rising demand for functional and natural components in pharmaceutical formulations and biotechnology applications. The development of vaccines, enzymes, and medicinal proteins frequently uses yeast extracts as nutrient-rich additions. Regulatory clearances and rising biopharmaceutical research expenditures are propelling market growth in Europe. Leading companies in the area are concentrating on developing new products to provide yeast-based goods with improved functional qualities. The market for yeast extracts is further supported by the pharmaceutical industry's growing customer preference for clean-label and plant-based treatments.
COMPETITION ANALYSIS
The major players in the yeast extract industry include AngelYeast Co., Ltd., Associated British Foods PLC, CELLSECO LTD., FUJIFILM Irvine Scientific, Kerry Group, Lallemand Inc., LESAFFRE GROUP, Merck KGaA, Nu-Tek BioSciences, Thermo Fisher Scientific Inc., and VWR International, LLC.
SOME KEY DEVELOPMENTS IN THE MARKET
Key Market Segments
Key Market Players